ATF5 and glioblastoma: In mice modelraised by C6 glioblastoma cells, ATF5-CaP-rHDL, ATF5-CaP-LNC and NC-CaP-rHDLwere given intravenously (i.v.)at the siRNA dose of0.36 mg kg−1 on day 6, 8, 10 and 12 aftersurgery.